Vanda Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$734.97 | $636.99 | 19.73% | 9 | $661.77B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$149.27 | $174.55 | 13.89% | 3 | $359.25B |
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.99B |
| ABBV | AbbVie | Outperform |
9
|
$163.79 | $178.42 | 12.95% | 11 | $290.01B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| KLAC | KLA Corp | Outperform |
8
|
$696.59 | $644.74 | 9.10% | 11 | $93.79B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| VTRS | Viatris Inc | Hold |
8
|
$11.78 | $11.73 | 6.11% | 5 | $13.74B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$68.80 | $79.10 | 31.54% | 10 | $7.26B |
| ALKS | Alkermes | Outperform |
10
|
$24.05 | $33.27 | 33.06% | 3 | $4.06B |
| INDV | Indivior PLC | Buy |
14
|
£14.35 | £28.89 | 115.54% | 4 | £1.95B |